Psycurio

What Psycurio does

PsyCurio GmbH is a German digital health company that develops and sells a virtual reality software platform for psychotherapy. The platform comprises 22 interactive, immersive 3D modules covering social anxiety, specific phobias (acrophobia, arachnophobia, claustrophobia), depression, PTSD/trauma, addiction (alcohol, tobacco, cannabis), meditation/mindfulness, and cognitive mini-games, with clinically validated methodologies including Virtual Reality Exposure Therapy (VRET) and an in-virtuo adaptation of Luise Reddemann's containment exercise. The software runs on standalone VR headsets — Meta Quest 3, Meta Quest 3s, Pico 4 Ultra Enterprise, and Pico 4 Enterprise — and is complemented by the PsyCurio Connect companion app on Android and Windows, which lets therapists monitor and switch sessions remotely. Headquartered in Bielefeld, Germany (registered in Paderborn), PsyCurio operates with a 1–10 person team and is led by Managing Director Daniela Schumacher.

The company monetizes primarily through annual software subscriptions: €1,145 per year per device for practices (unlimited users and modules) and custom multi-device contracts with premium support for clinics. Hardware is supplied indirectly through a core distribution partnership with VR-Expert, which ships headsets with PsyCurio software pre-installed, reducing setup friction for non-technical buyers. The customer base splits between independent psychotherapy practices, hospital clinics and rehabilitation centers, and — to a lesser extent — corporate workplace health programs (BGM). Named reference customers include AOK Rhein-Neckar-Odenwald, Psychiatriezentrum für junge Erwachsene Thun (PZJE), Klinik- und Rehabilitationszentrum Lippoldsberg, and santé24.

PsyCurio's go-to-market is sales-led and event-driven: customer acquisition starts with a free video demo booked via Google Calendar, supported by attendance at industry conferences (e.g., German Congress for Psychosomatic Medicine and Psychotherapy), educational webinars, and content marketing via blog and social channels (LinkedIn, Instagram). The company is GDPR-compliant, with personal data encrypted and stored locally on devices by default. It is supported by three accelerator relationships — Osnabrück Health Accelerator (OHA), German Accelerator Health (2023 alumni), and EIT Health Catapult — alongside memberships in HiNNK, the ATLAS Network for Digital Health, Healthcare Futurists, 5-HT Chemistry & Health, FiHH, and Therapy-Lift. No external parent, private equity backing, or institutional investor is disclosed in available sources, consistent with a bootstrapped, founder-led capital structure.

Name

Psycurio

Legal name

PsyCurio GmbH

Website

https://psycurio.de

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

PsyCurio GmbH is a German digital health company selling a VR software platform of 22 clinically validated therapy modules used by psychotherapists, clinics, and corporate health programs across the DACH region via annual per-device subscriptions and a VR-Expert hardware distribution partnership.

Ownership category

akta.pro rank

Product category

Digital Health Software

NAICS

Outpatient Mental Health and Substance Abuse Centers (62142)

SIC

Services-Prepackaged Software (7372), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

General Mental Health Therapy Platforms (Talk Therapy) (HLALAEAA)

akta.pro secondary industry

Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ)

Keywords

• VR therapy software
• Virtual reality exposure therapy
• Digital mental health
• Psychotherapy VR platform
• Clinical VR modules

Headquarters

HQ city

Münster

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Software Licensing (Subscription): Annual subscription model providing access to VR therapy software platform. For practices: €1145/year per device license with unlimited users and all VR modules included. For clinics: custom pricing for multiple devices with premium support.
2. Hardware Sales via Partner: VR headsets (Meta Quest 3, Quest 3s, Pico 4 Enterprise) sold through partner company VR-Expert. Software comes pre-installed on headsets, simplifying setup for customers.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

PsyCurio develops a clinically validated virtual reality software platform that delivers 22 interactive and immersive VR therapy modules for psychotherapists and clinics. The software runs on standalone VR headsets (Meta Quest 3, Quest 3s, Pico 4 Enterprise) and supports treatment of social anxiety, specific phobias (acrophobia, arachnophobia, claustrophobia), depression, PTSD/trauma, and addiction disorders. A companion app (PsyCurio Connect) enables therapists to control sessions remotely from Android or Windows devices.

Product overview

PsyCurio is a VR-based therapy platform offering 22 interactive and immersive virtual reality modules designed to complement psychotherapy sessions. The core platform is PsyCurio VR Therapy Software, which runs on VR headsets (Meta Quest 3, Meta Quest 3s, Pico 4 Ultra Enterprise, Pico 4 Enterprise). The product portfolio includes specialized treatment modules for specific phobias (Acrophobia, Arachnophobia, Claustrophobia), Social Anxiety, PTSD/Trauma (Containment Exercise), Addiction, Depression (with Psychoeducation, Autobiographical Exercises, and Meditation/Mindfulness modules), plus Mini-Games for gamification. The PsyCurio Connect App is a companion application for Android and Windows devices. Pricing tiers include For Practices (€1145/year for single device) and For Clinics (custom pricing for multiple devices).

Differentiator

Problem solved

Functional benefit

Brands

• PsyCurio Connect App: Mobile application allowing therapists to control VR therapy sessions from Android and Windows devices, view patient perspective, and switch environments without removing the headset.
• PsyCurio Connect

Products and services

• PsyCurio VR Therapy Platform A clinically validated virtual reality software platform designed to assist psychotherapists in treating mental health conditions including social anxiety, specific phobias, depression, PTSD/trauma, and addiction disorders through immersive VR exposure scenarios. Distributed as an annual software subscription per device with all modules included.
• PsyCurio Connect App Companion application for Android and Windows devices that allows therapists to remotely control VR therapy sessions, view the patient's perspective, and switch between therapy environments and modules without needing to put on the VR headset.

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• VR-ExpertcoreChannel Partner/ Reseller/ DistributorVR-Expert is PsyCurio's hardware distribution partner, responsible for shipping VR headsets (Meta Quest 3, Quest 3s, Pico 4 Enterprise) to customers with PsyCurio software pre-installed. This partnership enables plug-and-play deployment without complex setup or additional hardware requirements.
• HiNNK (Healthcare INNK)minorGTM or Marketing PartnerPsyCurio is a validated partner of HiNNK (Healthcare-Innk), a healthcare network organization supporting digital health innovations in the InnKrems region.
• ATLAS Network for Digital HealthminorGTM or Marketing PartnerMember of the ATLAS Network for digital health economy, connecting digital health companies for collaboration and visibility.
• Healthcare FuturistsminorStrategic or Co-development PartnerStrategic partnership with Healthcare Futurists organization, likely focused on industry trend identification and strategic positioning within digital health.
• 5-HT Chemistry & HealthminorGTM or Marketing PartnerPartnership with 5-HT Chemistry & Health platform, a digital hub connecting innovations in chemistry and health sectors.
• FiHH (Forschungsinstitut für Rehabilitationsmedizin)minorGTM or Marketing PartnerCollaboration with FiHH (Forschungsinstitut für Horizontale Hilfsmittelforschung), hosting VR therapy webinars for therapists.
• Therapy-LiftminorGTM or Marketing PartnerBusiness partnership with Therapy-Lift, a platform supporting therapy and rehabilitation services.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• XRHealth: US- and Israel-based VR therapy platform offering clinician-supervised VR modules for mental health (anxiety, PTSD, ADHD) and physical rehabilitation, sold on a subscription model to clinics and patients — directly comparable offering, customer base, and GTM motion.
• BehaVR: US-based VR therapeutics company building immersive multi-session programs for mental health (anxiety, depression, stress) and chronic pain, sold to providers and payers — comparable modality and clinical positioning.
• Amelia Virtual Care: Spanish/European VR mental-health platform providing VRET-based modules for anxiety, phobias, PTSD, and eating disorders to clinical professionals — closest European direct peer in scope, clinical methodology, and target buyer.
• C2Care: France-based developer of VR exposure-therapy software (anxiety disorders, phobias, OCD, PTSD) distributed to clinicians and hospitals in Europe — highly comparable in product, indications addressed, and clinical B2B model.

Emerging players

• SyncThink: US-based VR/eye-tracking platform for neurological assessment and rehabilitation (concussion, vestibular, brain-health) — adjacent in VR-for-clinical-use but focused on neurological assessment rather than psychotherapy.
• gameChange VR (Oxford VR): UK-developed automated VR therapy for psychosis and serious mental illness, with NHS-backed clinical trials — overlapping VR-psychotherapy space but focused on a narrower, higher-acuity indication than PsyCurio.

Others

• Psious: Historical VR-exposure-therapy platform targeting therapists in anxiety/PTSD treatment — comparable legacy product but limited recent commercial activity; included for category context rather than active competition.

Broad incumbents

• MindMaze: Well-funded Swiss digital-neurotherapeutics company combining VR, AI, and gamification across stroke rehab, Parkinson's, and mental health — broader portfolio than PsyCurio, but overlapping technology stack and European clinical-customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/psycurio
• Instagraminstagram.com/psycurio

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Psycurio